Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Northland Capital Markets Maintains Outperform on MaxLinear, Lowers Price Target to $25

Author: Benzinga Newsdesk | July 25, 2024 01:46pm
Northland Capital Markets analyst Tim Savageaux maintains MaxLinear (NASDAQ:MXL) with a Outperform and lowers the price target from $30 to $25.

Posted In: MXL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist